Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role Of Tumescence In Split Thickness Skin Grafting For Reconstruction Of Head And Neck Cancer Resection

NCT04967391 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT04967391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04967391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role Of Tumescence In Split Thickness Skin Grafting For Reconstruction Of Head And Neck Cancer Resection
Lead sponsor
University of California, Davis
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 1, 2021
Completion date
August 30, 2026
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft failure, head and neck cancer, surgery--complications